Correlation of macroscopic and microscopic pathology in risk reducing salpingo-oophorectomy: Implications for intraoperative specimen evaluation

被引:9
|
作者
Rabban, Joseph T. [1 ]
Mackey, Amber [1 ]
Powell, C. Bethan [2 ]
Crawford, Beth [3 ]
Zaloudek, Charles J. [1 ]
Chen, Lee-may [2 ]
机构
[1] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94313 USA
[2] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94313 USA
[3] UCSF Helen Diller Family Comprehens Canc Ctr, Canc Risk Program, San Francisco, CA USA
关键词
Risk-reducing salpingo-oophorectomy; Intraoperative evaluation; Occult carcinoma; BRCA; Fallopian tube; FALLOPIAN-TUBE; PROPHYLACTIC OOPHORECTOMY; MUTATION CARRIERS; FROZEN-SECTION; FORMALIN FIXATION; BRCA MUTATIONS; OVARIAN-TUMORS; BREAST-CANCER; WOMEN; CARCINOMA;
D O I
10.1016/j.ygyno.2011.01.031
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. A minority of risk-reducing salpingo-oophorectomy (RRSO) specimens from BRCA mutation carriers will contain clinically occult carcinoma that is detectable only using a specialized pathologic evaluation protocol. Although intraoperative detection of cancer may alter immediate surgical management, technical complications impairing pathologic diagnosis may result if fresh tissue dissection and frozen sections are performed on unselected RRSO specimens. We hypothesize that macroscopic specimen findings may predict which RRSO specimens contain cancer and therefore may guide selection of specimens for intraoperative pathologic evaluation. The aim of this study was to correlate the macroscopic and microscopic pathologic findings in RRSO. Methods. RRSO specimens from 134 women with a BRCA mutation were retrospectively classified by their grossly visible findings (cysts and/or nodules versus grossly unremarkable). Correlation of the gross findings with the microscopic finding of occult tubal and/or ovarian carcinoma was performed by re-examination of all pathology slides. Results. While 46% of RRSO had visible ovarian cysts and 34% had visible tubal/paratubal cysts, no cyst contained cancer on microscopic examination. Carcinoma was detected in 2/22 (9%) visible ovarian nodules and in 2/8 (25%) visible tubal nodules. Conversely, among all 11 RRSO specimens containing cancer, 7 (64%) had no corresponding visible abnormality. Conclusion. Frozen section evaluation of a solid nodule may be valuable in patients consented for immediate surgical staging. Otherwise it is best to avoid intraoperative dissection or frozen section of RRSO that are macroscopically normal or contain only cysts; such specimens should remain undissected for immediate formalin-fixation as the first step of the specialized pathology evaluation protocol. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:466 / 471
页数:6
相关论文
共 50 条
  • [41] Relationship satisfaction predicts sexual activity following risk-reducing salpingo-oophorectomy
    Lorenz, Tierney
    McGregor, Bonnie
    Swisher, Elizabeth
    JOURNAL OF PSYCHOSOMATIC OBSTETRICS AND GYNECOLOGY, 2014, 35 (02) : 62 - 68
  • [42] Clinical background and outcomes of risk-reducing salpingo-oophorectomy for hereditary breast and ovarian cancers in Japan
    Nomura, Hidetaka
    Sekine, Masayuki
    Yokoyama, Shiro
    Arai, Masami
    Enomoto, Takayuki
    Takeshima, Nobuhiro
    Nakamura, Seigo
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (09) : 1105 - 1110
  • [43] Selected features of breast and peritoneal cancers diagnosed in BRCA1 carriers after risk-reducing salpingo-oophorectomy
    Menkiszak, Janusz
    Chudecka-Glaz, Anita
    Cymbaluk-Ploska, Aneta
    Celewicz, Aleksander
    Kojs, Zbigniew
    Szajda, Mariusz
    Swiniarska, Maria
    Bedner, Ryszard
    Jurczak, Anna
    Celewicz, Marta
    Cieszynska, Monika
    Lubinski, Jan
    Gronwald, Jacek
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2019, 17 (1)
  • [44] Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy
    Powell, C. B.
    Swisher, E. M.
    Cass, I.
    McLennan, J.
    Norquist, B.
    Garcia, R. L.
    Lester, J.
    Karlan, B. Y.
    Chen, L.
    GYNECOLOGIC ONCOLOGY, 2013, 129 (02) : 364 - 371
  • [45] Surveillance of survivors: Follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers
    Chapman, Jocelyn S.
    Powell, C. Bethan
    McLennan, Jane
    Crawford, Beth
    Mak, Julie
    Stewart, Nicola
    Chen, Lee-may
    GYNECOLOGIC ONCOLOGY, 2011, 122 (02) : 339 - 343
  • [46] “Best practices in risk reducing bilateral salpingo-oophorectomy: the influence of surgical specialty”
    Dominique R. Malacarne
    Leslie R. Boyd
    Yang Long
    Stephanie V. Blank
    World Journal of Surgical Oncology, 15
  • [47] Long-Term Non-Cancer Risks in People with BRCA Mutations following Risk-Reducing Bilateral Salpingo-Oophorectomy and the Role of Hormone Replacement Therapy: A Review
    Nitschke, Amanda S. S.
    do Valle, Helena Abreu
    Dawson, Lesa
    Kwon, Janice S. S.
    Hanley, Gillian E. E.
    CANCERS, 2023, 15 (03)
  • [48] Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis
    Gaba, Faiza
    Blyuss, Oleg
    Tan, Alex
    Munblit, Daniel
    Oxley, Samuel
    Khan, Khalid
    Legood, Rosa
    Manchanda, Ranjit
    CANCERS, 2023, 15 (05)
  • [49] Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy
    Natalia Teixeira
    Marian J. Mourits
    Jan C. Oosterwijk
    Ingrid E. Fakkert
    Anthony R. Absalom
    Stephan J. L. Bakker
    Peter van der Meer
    Geertruida H. de Bock
    Familial Cancer, 2019, 18 : 19 - 27
  • [50] Use of hormone replacement therapy after risk-reducing salpingo-oophorectomy
    Johansen, Nora
    Liavaag, Astrid H.
    Iversen, Ole-Erik
    Dorum, Anne
    Braaten, Tonje
    Michelsen, Trond M.
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2017, 96 (05) : 547 - 555